BH3-Only Protein Expression Determines Hepatocellular Carcinoma Response to Sorafenib-Based Treatment

In the presence of NOXA, BIM-deficient hepatocellular carcinoma cells could be in turn strongly sensitized for cell death induction by the combination of sorafenib with TNF-related apoptosis-inducing ligand .